Format

Send to

Choose Destination
FEBS Lett. 2006 Feb 13;580(4):998-1009. Epub 2005 Dec 28.

The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research.

Author information

1
Laboratory of Cell Biology, The Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. mgottesman@nih.gov

Abstract

The discovery and characterization of P-glycoprotein, an energy-dependent multidrug efflux pump, as a mechanism of multidrug resistance in cancer is generally accepted as a significant contribution to the ongoing effort to end death and suffering from this disease. The historical reflections of Victor Ling and Michael Gottesman concerning the early years of this research highlight the important contributions of the multidisciplinary teams involved in these studies, and illustrate how technological developments in biochemistry and molecular and cell biology enabled this discovery.

PMID:
16405967
DOI:
10.1016/j.febslet.2005.12.060
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center